could
149 articole · RSS
Potential rise in SIF stake cap could aid stock market rebound
The SIFs decline halted during the last two sessions of last week, after SIF Banat-Crisana (SIF1) and SIF Moldova (SIF2) announced they would propose to their shareholders an increase to the...
Capital Partners: Eurisko's sale could have been blocked
The sale of the real estate consulting company Eurisko to the American giant CB Richard Ellis for 35 million dollars was one of the most complex transactions carried out on the Romanian mark...
thegroup: Advertising market could face crisis in 2 years
The local advertising market will not maintain the same growth rate that it registered over the last few years and could even enter a period of crisis, according to Zoltan Szigeti, president...
UBS: RON depreciation could be beneficial
A controlled depreciation of the RON could eventually prove beneficial for the economy, as it will restore balance to the system and remove what we think are currently "over exaggerated fear...
Orban: EC could launch excessive budget deficit procedures
The European Commission could ask Romania to reduce its budget deficit by means of the excessive deficit procedure if the Government does not take steps to limit the budget deficit by May. "...
NBR could increase interest rate to 9%
The NBR (National Bank of Romania) will increase the key interest rate for RON by at least half a percentage point today, to 8.5% a year, and is expected to continue to apply a moderate incr...
State could receive 2bn euros from CFR Marfa's privatisation
State-held company CFR Marfa (a freight operator), which is expected to complete its privatisation strategy in around three months, is worth somewhere between one and three billion euros, ac...
Carrefour could tap into discount store market
French retailer Carrefour is holding talks to take over Plus Discount stores in Romania through an international transaction, after it entered the supermarket segment with the acquisition of...
Merck could relocate some operations to Romania
American giant Merck Sharp&Dohme (MSD), one of the top ten producers of patent drugs worldwide, is examining the possibility of relocating some of its operations to Central and Eastern Europ...